Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis-Reference-Cited by-同舟云学术

Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis

Published:2020-07-07 Issue: Volume: Page:
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Zieglmayer Petra¹²^ORCID,Schmutz René¹³,Lemell Patrick¹^ORCID,Unger‐Manhart Nicole⁴,Nakowitsch Sabine⁴,Goessl Andreas⁴,Savli Markus⁵,Zieglmayer René¹,Prieschl‐Grassauer Eva⁴

Affiliation:

1. Power Project GmbHVienna Challenge Chamber Vienna Austria

2. Medical University Vienna Austria

3. Medical SchoolSigmund Freud University Vienna Austria

4. Marinomed Biotech AG Vienna Austria

5. Biostatistik & Consulting Hartberg Austria

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13691

Reference36 articles.

1. AkdisCA HellingsPW AgacheI.Global atlas of allergic rhinitis and chronic rhinosinusitis;2015.

2. The link between allergic rhinitis and allergic asthma: A prospective population-based study. The Copenhagen Allergy Study

3. Rhinitis as an independent risk factor for adult-onset asthma

4. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications

5. Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

2. Alleviation of allergic rhinoconjunctivitis symptoms in participants treated with a 0.005% tacrolimus eye drop solution;2024-05-01

3. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06

4. Biomarkers of airway inflammation and immunotherapy;Clinical & Experimental Allergy;2022-05-30

5. Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs;Pharmaceutics;2022-03-08